[Enzyme induction in newborn infants--principles of medicamentous prevention of hyperbilirubinemia].
D000818:Animals; D004790:Enzyme Induction / Q000187:drug effects*; D004837:Epinephrine / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005696:Galactosidases / Q000378:metabolism; D005934:Glucagon / Q000627:therapeutic use; D005943:Gluconeogenesis / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology / Q000627:therapeutic use; D006932:Hyperbilirubinemia / Q000517:prevention & control*; D007231:Infant, Newborn; D008099:Liver / Q000201:enzymology; D051379:Mice; D010634:Phenobarbital / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats
D005934:Glucagon; D005696:Galactosidases; D006854:Hydrocortisone; D004837:Epinephrine; D010634:Phenobarbital
Enzyminduktion bei Neugeborenen--Grundlage medikamentöser Prophylaxe der Hyperbilirubinämie.